tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
GNCA is currently covered by 3 analysts with an average price target of $21.93. This is a potential upside of $21.93 (0%) from yesterday's end of day stock price of $0.
Genocea Biosciences's activity chart (see below) currently has 17 price targets and 27 ratings on display. The stock rating distribution of GNCA is 100% HOLD.
Analysts average stock forecasts to be materialized ratio is 20.56% with an average time for these price targets to be met of 18.17 days.
Most recent stock forecast was given by STEPHEN WILLEY from STIFEL on 29-Apr-2022. First documented stock forecast 05-Mar-2014.
Currently out of the existing stock ratings of GNCA, 3 are a HOLD (100%).
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
1 years 11 months 24 days ago
0/2 (0%)
$10 (100.00%)
Hold
0.16
$0.16 (0.00%)
18
1 years 11 months 24 days ago
1/3 (33.33%)
$-0.12 (-42.86%)
25
Hold
9
1 years 11 months 24 days ago
1/2 (50%)
$5.4 (150.00%)
4
Buy
3 years 2 months 11 days ago
0/1 (0%)
$9.91 (162.73%)
Buy
16
$16 (0.00%)
6 years 2 months 7 days ago
0/1 (0%)
$8.16 (104.08%)
What is GNCA (Genocea Biosciences) average time for price targets to be met?
Which analyst has the current highest performing score on GNCA (Genocea Biosciences) with a proven track record?
Which analyst has the current lower performing score on GNCA (Genocea Biosciences) with a proven track record?
Which analyst has the most public recommendations on GNCA (Genocea Biosciences)?
Which analyst is the currently most bullish on GNCA (Genocea Biosciences)?
Which analyst is the currently most reserved on GNCA (Genocea Biosciences)?
